Xiangyang Cheng

Xiangyang Cheng

Auto-generated profile, based on publicly available information

Xiangyang Cheng

Anesthesiology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, Shanghai, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
XCXiangyang Cheng
Xiangyang Cheng
XZXiao Zhang
Xiao Zhang
JZJie Zhang
Jie Zhang
ZHZhenhua Hu
Zhenhua Hu
JZjiaqiang zhang
jiaqiang zhang
DSDiansan Su
Diansan Su
Objective: The incidence of hypoxia in painless gastrointestinal endoscopy is not negligible. A nasal mask oxygen kit may reduce the incidence of hypoxia compared with a regular nasal cannula. Methods: This multi-centre, randomised, open-label clinical trial took place from 1 September 2022 to 6 June 2023 in three Chinese teaching hospitals. Participants were randomly assigned 1:1 to either the intervention or the control group. Before induction of anaesthesia, a nasal cannula was used in the control group, and a nasal mask oxygen kit was used in the intervention group. The primary outcome was hypoxia (peripheral capillary oxygen saturation (SpO 2 ) ≥75% but <90% for <60 s). Secondary outcomes were subclinical respiratory depression (SpO 2 ≥90% but <95%), severe hypoxia (SpO 2 <75% or SpO 2 ≥75% but <90% for ≥60 s) and other adverse events. Results: Among the 1204 initially enrolled patients, 1197 completed the study, with 597 randomised to the nasal mask oxygen kit group and 600 to the control group. Compared with the control group, the nasal mask oxygen kit significantly reduced the incidence of hypoxia during gastrointestinal endoscopy under sedation (12.5% vs 7.4%; rate difference (RD) = 0.051; 95% CI 0.018 to 0.085; p=0.003), subclinical respiratory depression (13% vs 9.4%; RD = 0.036; 95% CI 0.0005 to 0.072; p=0.047) and total adverse events (27.5% vs 18.6%; RD = 0.089; 95% CI 0.042 to 0.137; p0.05). Conclusions: The nasal mask oxygen kit can decrease the incidence of hypoxia in patients with American Society of Anesthesiologists class I/II undergoing gastrointestinal endoscopy under propofol and fentanyl sedation. Trial registration number: NCT05405530 .